P06.10.B POSTOPERATIVE COGNITIVE TRAJECTORY OF PATIENTS WITH GIANT IDH MUTATED GLIOMAS

Abstract BACKGROUND IDH mutated gliomas are in many instances causing cognitive impairment already at time of diagnosis. In addition, the treatment may also cause cognitive decline. The negative cognitive impact may potentially be higher in the largest tumors, but there has been limited research on the cognitive effects of giant (≥ 100 ml) IDH mutated tumors. We aimed to study the 1-year trajectories of cognitive functions in patients with giant IDH mutated gliomas after resective surgery MATERIAL AND METHODS This was a prospective, population-based study in patients with giant (≥ 100 ml) IDH mutated gliomas. A cognitive test battery was used to assess cognitive performance in the domains executive function, memory, visuospatial function, language, processing speed and attention. Preoperative test reslts were compared with three month and 12 month postoperative test results, respectively, excluding executive and visuospatial function at three months postoperative (shorter test battery at three months). Both individual and domain-level analyses were done. RESULTS Eighteen patients were included. Median age was 44.5 years (40.2-54.2). Ten patients were male (55.6%). Median tumor volume was 125.3 ml (113-135), and median extent of resection was 86.3% (72%-92.3%). At three months for the domains, improvements were seen in memory (p < 0.05) and processing speed (p < 0.05). No significant cognitive test or domain changes were seen when comparing baseline with performance at 12 months after surgery. CONCLUSION Despite the intimidating size, cognitive trajectories are favorable in giant IDH mutated gliomas. The limited sample size limits us from drawing firm conclusions.

Authors

Institutions

Publication Details

Journal
Neuro-Oncology
Published
2025-10-01
DOI
https://doi.org/10.1093/neuonc/noaf193.242
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

P06.10.B POSTOPERATIVE COGNITIVE TRAJECTORY OF PATIENTS WITH GIANT IDH MUTATED GLIOMAS

Isabelle Rydén, Anna Lipatnikova, Ádám Dénes, Asgeir Store Jakola et al.
Neuro-Oncology
Glioma Diagnosis and Treatment
article

P06.10.B POSTOPERATIVE COGNITIVE TRAJECTORY OF PATIENTS WITH GIANT IDH MUTATED GLIOMAS

Isabelle Rydén, Anna Lipatnikova, Ádám Dénes, Asgeir Store Jakola, M.A Masri
article en

Abstract

Abstract BACKGROUND IDH mutated gliomas are in many instances causing cognitive impairment already at time of diagnosis. In addition, the treatment may also cause cognitive decline. The negative cognitive impact may potentially be higher in the largest tumors, but there has been limited research on the cognitive effects of giant (≥ 100 ml) IDH mutated tumors. We aimed to study the 1-year trajectories of cognitive functions in patients with giant IDH mutated gliomas after resective surgery MATERIAL AND METHODS This was a prospective, population-based study in patients with giant (≥ 100 ml) IDH mutated gliomas. A cognitive test battery was used to assess cognitive performance in the domains executive function, memory, visuospatial function, language, processing speed and attention. Preoperative test reslts were compared with three month and 12 month postoperative test results, respectively, excluding executive and visuospatial function at three months postoperative (shorter test battery at three months). Both individual and domain-level analyses were done. RESULTS Eighteen patients were included. Median age was 44.5 years (40.2-54.2). Ten patients were male (55.6%). Median tumor volume was 125.3 ml (113-135), and median extent of resection was 86.3% (72%-92.3%). At three months for the domains, improvements were seen in memory (p < 0.05) and processing speed (p < 0.05). No significant cognitive test or domain changes were seen when comparing baseline with performance at 12 months after surgery. CONCLUSION Despite the intimidating size, cognitive trajectories are favorable in giant IDH mutated gliomas. The limited sample size limits us from drawing firm conclusions.

Neuro-OncologyVol. 27(Supplement_3)
Sahlgrenska University Hospital (SE), Neuroscience Institute (IT), Center for Neurosciences (US), University of Gothenburg (SE)
Openalex Percentile: Top 62%
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.